跳至主要内容
临床试验/EUCTR2016-000246-62-Outside-EU/EEA
EUCTR2016-000246-62-Outside-EU/EEA进行中(未招募)1 期

A Study of Magnetic Resonance Imaging Assessment of Cardiac and Liver Iron Load in Patients With Haemoglobinopathies, Myelodysplastic Syndromes (MDS) or Other Anaemias Treated With Exjade® (Deferasirox) (The MILE Study)

ovartis0 个研究点目标入组 53 人开始时间: 2016年3月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
ovartis
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Male or female WITH haemoglobinopathy, Myelodysplastic Syndromes or other inherited or acquired anaemia (e.g. MPD, Diamond-blackfan anaemia and other rare anaemias) patients = 18 years and weighing >40kg.
  • Lifetime minimum of > 20 units of packed red blood cell transfusions
  • Normal or minimally abnormal cardiac function
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 5
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 41
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 7

排除标准

  • Contraindication to MRI scans
  • High risk myelodysplastic syndromes patients and patients with other haematological and non-haematological malignancies who are not expected to benefit from chelation therapy due to the rapid progression of their disease
  • Patients with uncontrolled high blood pressure
  • An organ transplant less than 3 months previously
  • Other protocol-defined inclusion/exclusion criteria may apply.

研究者

发起方
ovartis

相似试验

Magnetic Resonance Imaging (MRI) Assessments of the... | 临床试验